American Academy of Child and Adolescent Psychiatry 57th Annual Meeting (October 26-31, 2010) Program Schedule
Please note that this schedule is subject to change.
Home | Search | Browse by Day or Program | Author Index | Browse Exhibitors

New Research Poster Presentation 3.51
Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (6–17 Years Old): Results From a 52-Week Open-Label Study
Thursday, October 28, 2010
Gina Lau, Pharm.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ
George Manos, Ph.D., Bristol Myers Squibb, Wallingford, CT
Robert D. McQuade, Ph.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
Lisa M. Kamen, M.A., R&D, Bristol Myers Squibb, Wallingford, CT
Ronald Marcus, M.D., Bristol Myers Squibb, Wallingford, CT
Raymond Mankoski, M.D., Ph.D., Bristol Myers Squibb, Plainsboro, NJ
See more of: New Research Poster Session 3
See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.